All the following are true about Atrial fibrillation, except
Increased risk of thromboembolism
Digoxin for treatment
Anticoagulantion not required
Aspirin in low risk patients
There are two approaches to mitigate the risk related to cardioversion. One option is to anticoagulate continuously for 3 weeks before and a minimum of 4 weeks after cardioversion. A second approach is to sta anticoagulation and perform a transesophageal echocardiogram to determine if throm- bus is present in the left atrial appendage Ref Harrison 20th edition pg 1576
C.V.S